You know what Scott, I owe you an apology. I read your last post incorrectly. I read words that were not there. I actually agree with you that hopefully it does not divert attention from those trials. I, incorrectly, thought you were implying that they wanted to divert attention because they believed the other trials were not likely to succeed. That is not what you said though.

If you have a minute or so, if you would invest it watching the following video, you might see what I believe and hope will be the case with Cellceutix. Especially with the first publication of Kevetrin approaching.

https://youtu.be/mC78slhAtzo?t=5289

If you have the time, watch till the end because he fielded a few questions that had to do with socialized medicine pricing etc.